data_2n0d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n0d _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.784 0.326 . . . . 72.430000000000007 110.789 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.17 -168.41 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 62.409999999999997 110.941 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.5 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 64.030000000000001 111.125 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.73 23.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 60.299999999999997 111.121 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 37.94 1.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 64.219999999999999 112.504 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 75.109999999999999 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -46.13 73.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 110.889 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.120000000000005 110.914 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.791 0.329 . . . . 65.010000000000005 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.88 -168.45 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.871 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.23 31.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.299999999999997 111.127 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 m -94.72 23.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 62.43 111.113 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 38.03 1.93 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.78 -0.724 . . . . 61.219999999999999 112.448 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -137.71 -53.31 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 70.109999999999999 110.872 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -52.04 35.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 71.200000000000003 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.781 0.324 . . . . 74.25 110.956 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -168.43 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 110.928 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.1 32.34 10.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.099999999999994 111.047 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.9 m -95.07 24.01 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 111.125 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.37 37.85 1.94 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.8 -0.714 . . . . 64.099999999999994 112.456 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.64 -52.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 71.430000000000007 110.837 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -27.06 65.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 110.876 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.109999999999999 110.905 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 74.439999999999998 110.845 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -168.55 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.943 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.33 31.62 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 111.062 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 m -94.91 23.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.119999999999997 111.025 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.14 37.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.239999999999995 112.479 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.77 -54.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 70.540000000000006 110.88 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -40.57 93.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 55.210000000000001 110.895 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 63.240000000000002 110.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.802 0.334 . . . . 71.310000000000002 110.863 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -168.38 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.129999999999995 110.907 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.2 32.01 10.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 111.082 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.1 23.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 74.120000000000005 111.033 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.02 37.8 1.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.811 -0.709 . . . . 74.219999999999999 112.535 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -137.64 -55.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.319999999999993 110.841 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 63.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 62.539999999999999 110.877 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.728 0.299 . . . . 74.540000000000006 110.8 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -168.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 110.912 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.59 10.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.040000000000006 111.065 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -94.89 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.134 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.87 1.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 74.129999999999995 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.68 -55.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.129999999999995 110.83 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.74 94.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.907 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 63.109999999999999 110.899 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.75 0.309 . . . . 73.200000000000003 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 -168.41 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 72.400000000000006 110.899 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 32.1 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 111.108 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.12 23.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 111.075 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 37.86 1.94 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.819 -0.705 . . . . 73.439999999999998 112.539 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.71 -55.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 74.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.28 93.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.899 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 65.239999999999995 110.845 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 75.109999999999999 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -168.37 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 72.549999999999997 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.83 10.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 111.059 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.0 m -94.9 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 64.010000000000005 111.085 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.81 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.819 -0.705 . . . . 64.310000000000002 112.505 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 75.140000000000001 110.818 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -47.03 81.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 72.349999999999994 110.841 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.856 0.36 . . . . 73.140000000000001 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.35 -168.48 1.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.549999999999997 110.95 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.16 10.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 111.183 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 32.7 m -94.97 24.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 74.099999999999994 111.09 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.8 37.73 1.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.54 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.7 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 74.340000000000003 110.89 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -28.87 68.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 73.150000000000006 110.936 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.488 ' HE1' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 43.030000000000001 110.841 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.783 0.325 . . . . 74.129999999999995 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -168.44 2.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 70.439999999999998 110.939 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.89 10.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 71.239999999999995 111.092 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.94 23.88 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 43.25 111.065 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.15 37.89 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 63.240000000000002 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 110.865 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -44.91 91.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.200000000000003 110.924 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.219999999999999 110.857 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 64.040000000000006 110.889 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -168.51 2.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 64.530000000000001 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 62.229999999999997 111.092 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.25 23.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 73.409999999999997 111.036 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.3 37.83 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.030000000000001 112.517 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.78 -55.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 72.319999999999993 110.856 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -49.58 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 73.099999999999994 110.885 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.894 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.762 0.315 . . . . 72.400000000000006 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -168.38 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 32.26 10.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 111.103 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.459 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 32.8 m -95.18 24.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.329999999999998 111.063 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.47 37.81 1.94 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 75.340000000000003 112.505 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -137.71 -54.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 75.400000000000006 110.913 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -35.24 80.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 70.219999999999999 110.852 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.75 0.309 . . . . 71.400000000000006 110.814 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.58 -168.52 1.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 72.019999999999996 110.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.3 31.96 10.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.519999999999996 110.989 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.03 23.72 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 62.219999999999999 111.029 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.03 37.91 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.831 -0.699 . . . . 61.439999999999998 112.518 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.76 -55.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 72.420000000000002 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -42.77 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 63.130000000000003 110.836 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 52.299999999999997 110.811 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.768 0.318 . . . . 64.310000000000002 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -168.49 2.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 33.04 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.519999999999996 111.09 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.8 23.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 111.166 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 37.92 1.95 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.819 -0.705 . . . . 74.450000000000003 112.553 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.73 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 75.109999999999999 110.841 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -26.91 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 110.982 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.842 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.785 0.326 . . . . 74.209999999999994 110.822 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.54 -168.58 0.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.030000000000001 110.929 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.54 10.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 65.239999999999995 111.039 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.85 23.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 111.062 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 38.03 1.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 72.200000000000003 112.483 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.71 -53.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 73.239999999999995 110.857 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -41.75 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.530000000000001 110.922 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 64.549999999999997 110.86 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m170 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.782 0.325 . . . . 62.219999999999999 110.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -168.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 74.200000000000003 110.987 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.5 10.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 60.32 111.04 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.0 m -94.89 23.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 111.027 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.79 37.88 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 33.210000000000001 112.516 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -54.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 44.009999999999998 110.818 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -38.49 88.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 73.150000000000006 110.881 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 60.329999999999998 110.819 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 m170 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.758 0.313 . . . . 75.120000000000005 110.828 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -168.4 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.65 10.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 111.193 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -94.82 23.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 111.044 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.72 37.74 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 43.229999999999997 112.455 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.62 -52.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.010000000000005 110.829 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -50.79 36.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.120000000000005 110.928 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 74.019999999999996 110.928 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.804 0.335 . . . . 62.340000000000003 110.811 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -168.39 2.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 74.120000000000005 110.928 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 72.329999999999998 111.129 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -94.89 23.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 64.219999999999999 111.073 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.74 37.81 1.97 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.812 -0.709 . . . . 60.030000000000001 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.65 -55.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 71.230000000000004 110.857 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -47.07 82.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.120000000000005 110.905 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.405 ' H ' ' HE3' ' A' ' 10' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.912 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.692 0.282 . . . . 65.030000000000001 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -168.5 1.94 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.921 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.25 33.92 8.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 50.210000000000001 111.051 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.66 23.45 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.026 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.08 37.97 1.93 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.817 -0.706 . . . . 71.010000000000005 112.45 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.69 -52.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 65.340000000000003 110.875 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -44.83 68.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.519999999999996 110.922 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.329999999999998 110.883 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.743 0.306 . . . . 51.439999999999998 110.864 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.31 -168.46 2.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 53.43 110.906 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.16 32.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.409999999999997 111.069 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -94.89 23.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 40.340000000000003 111.034 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.26 37.78 1.95 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 24.440000000000001 112.473 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.74 -55.76 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.733 0.302 . . . . 75.310000000000002 110.816 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -41.63 98.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 71.120000000000005 110.915 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 65.540000000000006 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.536 -0.226 . . . . 74.109999999999999 112.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -114.35 145.6 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 72.019999999999996 110.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -53.87 -65.23 0.6 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 72.430000000000007 110.789 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.17 -168.41 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 62.409999999999997 110.941 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.5 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 64.030000000000001 111.125 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.73 23.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 60.299999999999997 111.121 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 37.94 1.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 64.219999999999999 112.504 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 75.109999999999999 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -46.13 73.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 110.889 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.120000000000005 110.914 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.536 -0.226 . . . . 64.109999999999999 112.536 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -95.11 139.58 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.351 . . . . 74.430000000000007 110.952 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -72.7 -66.91 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 65.010000000000005 110.869 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.88 -168.45 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.871 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.23 31.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.299999999999997 111.127 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 m -94.72 23.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 62.43 111.113 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 38.03 1.93 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.78 -0.724 . . . . 61.219999999999999 112.448 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -137.71 -53.31 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 70.109999999999999 110.872 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -52.04 35.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 71.200000000000003 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.553 -0.219 . . . . 50.549999999999997 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.04 125.22 29.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 61.530000000000001 110.872 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -57.28 -64.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 74.25 110.956 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -168.43 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 110.928 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.1 32.34 10.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.099999999999994 111.047 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.9 m -95.07 24.01 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 111.125 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.37 37.85 1.94 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.8 -0.714 . . . . 64.099999999999994 112.456 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.64 -52.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 71.430000000000007 110.837 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -27.06 65.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 110.876 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.109999999999999 110.905 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.492 -0.243 . . . . 71.219999999999999 112.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -154.49 179.62 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 71.140000000000001 110.879 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.77 -58.16 8.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 74.439999999999998 110.845 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -168.55 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.943 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.33 31.62 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 111.062 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 m -94.91 23.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.119999999999997 111.025 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.14 37.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.239999999999995 112.479 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.77 -54.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 70.540000000000006 110.88 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -40.57 93.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 55.210000000000001 110.895 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 63.240000000000002 110.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.433 -0.267 . . . . 55.039999999999999 112.433 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 149.58 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 71.120000000000005 110.839 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -101.04 -41.81 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 71.310000000000002 110.863 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -168.38 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.129999999999995 110.907 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.2 32.01 10.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 111.082 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.1 23.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 74.120000000000005 111.033 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.02 37.8 1.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.811 -0.709 . . . . 74.219999999999999 112.535 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -137.64 -55.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.319999999999993 110.841 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 63.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 62.539999999999999 110.877 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.513 -0.235 . . . . 71.140000000000001 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -102.92 152.02 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 75.150000000000006 110.918 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -118.41 -60.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.540000000000006 110.8 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -168.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 110.912 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.59 10.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.040000000000006 111.065 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -94.89 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.134 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.87 1.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 74.129999999999995 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.68 -55.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.129999999999995 110.83 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.74 94.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.907 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 63.109999999999999 110.899 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.499 -0.24 . . . . 71.540000000000006 112.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -116.61 90.65 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 75.439999999999998 110.894 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -53.93 -57.39 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.200000000000003 110.901 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 -168.41 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 72.400000000000006 110.899 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 32.1 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 111.108 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.12 23.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 111.075 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 37.86 1.94 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.819 -0.705 . . . . 73.439999999999998 112.539 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.71 -55.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 74.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.28 93.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.899 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 65.239999999999995 110.845 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.507 -0.237 . . . . 31.050000000000001 112.507 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -110.76 142.54 42.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 60.43 110.932 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.69 -64.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 110.846 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -168.37 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 72.549999999999997 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.83 10.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 111.059 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.0 m -94.9 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 64.010000000000005 111.085 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.81 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.819 -0.705 . . . . 64.310000000000002 112.505 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 75.140000000000001 110.818 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -47.03 81.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 72.349999999999994 110.841 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.448 -0.261 . . . . 65.239999999999995 112.448 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -85.62 176.01 8.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 72.040000000000006 110.901 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -54.06 -48.66 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 73.140000000000001 110.883 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.35 -168.48 1.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.549999999999997 110.95 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.16 10.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 111.183 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 32.7 m -94.97 24.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 74.099999999999994 111.09 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.8 37.73 1.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.54 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.7 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 74.340000000000003 110.89 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -28.87 68.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 73.150000000000006 110.936 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.488 ' HE1' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 43.030000000000001 110.841 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.464 -0.254 . . . . 73.439999999999998 112.464 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.12 176.29 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 72.510000000000005 110.888 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.05 -68.56 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.129999999999995 110.873 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -168.44 2.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 70.439999999999998 110.939 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.89 10.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 71.239999999999995 111.092 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.94 23.88 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 43.25 111.065 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.15 37.89 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 63.240000000000002 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 110.865 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -44.91 91.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.200000000000003 110.924 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.219999999999999 110.857 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.484 -0.246 . . . . 63.119999999999997 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -112.31 -179.06 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 74.420000000000002 110.867 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -114.51 -68.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 64.040000000000006 110.889 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -168.51 2.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 64.530000000000001 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 62.229999999999997 111.092 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.25 23.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 73.409999999999997 111.036 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.3 37.83 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.030000000000001 112.517 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.78 -55.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 72.319999999999993 110.856 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -49.58 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 73.099999999999994 110.885 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.894 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.475 -0.25 . . . . 54.43 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.15 83.86 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 74.010000000000005 110.851 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -53.76 -59.74 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 72.400000000000006 110.831 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -168.38 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 32.26 10.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 111.103 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.459 ' HA ' ' HE1' ' A' ' 10' ' ' MET . 32.8 m -95.18 24.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.329999999999998 111.063 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.47 37.81 1.94 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 75.340000000000003 112.505 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -137.71 -54.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 75.400000000000006 110.913 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -35.24 80.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 70.219999999999999 110.852 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.462 -0.255 . . . . 74.329999999999998 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.37 149.66 48.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.379 . . . . 72.25 110.868 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -99.18 -62.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 71.400000000000006 110.814 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.58 -168.52 1.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 72.019999999999996 110.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.3 31.96 10.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.519999999999996 110.989 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.03 23.72 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 62.219999999999999 111.029 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.03 37.91 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.831 -0.699 . . . . 61.439999999999998 112.518 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.76 -55.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 72.420000000000002 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -42.77 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 63.130000000000003 110.836 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 52.299999999999997 110.811 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.522 -0.231 . . . . 65.409999999999997 112.522 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -139.08 161.61 36.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.367 . . . . 74.120000000000005 110.875 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -77.4 -71.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 110.905 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -168.49 2.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 33.04 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.519999999999996 111.09 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.8 23.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 111.166 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 37.92 1.95 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.819 -0.705 . . . . 74.450000000000003 112.553 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.73 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 75.109999999999999 110.841 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -26.91 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 110.982 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.842 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.396 -0.282 . . . . 75.140000000000001 112.396 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -173.83 131.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 70.150000000000006 110.842 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -105.36 -25.92 12.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.822 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.54 -168.58 0.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.030000000000001 110.929 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.54 10.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 65.239999999999995 111.039 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.85 23.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 111.062 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 38.03 1.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 72.200000000000003 112.483 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.71 -53.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 73.239999999999995 110.857 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -41.75 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.530000000000001 110.922 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 64.549999999999997 110.86 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.465 -0.254 . . . . 62.32 112.465 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -116.13 123.0 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 75.409999999999997 110.873 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -97.79 -26.18 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 62.219999999999999 110.888 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -168.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 74.200000000000003 110.987 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.5 10.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 60.32 111.04 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.0 m -94.89 23.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 111.027 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.79 37.88 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 33.210000000000001 112.516 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -54.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 44.009999999999998 110.818 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -38.49 88.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 73.150000000000006 110.881 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 60.329999999999998 110.819 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.473 -0.251 . . . . 63.149999999999999 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.32 114.16 26.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 73.209999999999994 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -79.16 -52.32 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.828 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -168.4 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.65 10.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 111.193 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -94.82 23.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 111.044 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.72 37.74 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 43.229999999999997 112.455 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.62 -52.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.010000000000005 110.829 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -50.79 36.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.120000000000005 110.928 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 74.019999999999996 110.928 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.478 -0.249 . . . . 33.039999999999999 112.478 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -121.99 168.07 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 75.209999999999994 110.894 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.05 -71.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 62.340000000000003 110.811 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -168.39 2.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 74.120000000000005 110.928 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 72.329999999999998 111.129 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -94.89 23.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 64.219999999999999 111.073 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.74 37.81 1.97 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.812 -0.709 . . . . 60.030000000000001 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.65 -55.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 71.230000000000004 110.857 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -47.07 82.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.120000000000005 110.905 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.405 ' H ' ' HE3' ' A' ' 10' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.912 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.494 -0.242 . . . . 51.5 112.494 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.46 161.34 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.34 . . . . 71.430000000000007 110.963 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -125.7 -57.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 65.030000000000001 110.796 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -168.5 1.94 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.921 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.25 33.92 8.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 50.210000000000001 111.051 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.66 23.45 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.026 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.08 37.97 1.93 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.817 -0.706 . . . . 71.010000000000005 112.45 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.69 -52.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 65.340000000000003 110.875 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -44.83 68.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.519999999999996 110.922 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.329999999999998 110.883 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.449 -0.261 . . . . 61.520000000000003 112.449 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -99.61 137.84 37.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 64.099999999999994 110.853 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -75.96 -66.08 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 51.439999999999998 110.864 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.31 -168.46 2.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 53.43 110.906 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.16 32.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.409999999999997 111.069 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -94.89 23.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 40.340000000000003 111.034 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.26 37.78 1.95 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 24.440000000000001 112.473 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.74 -55.76 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.733 0.302 . . . . 75.310000000000002 110.816 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -41.63 98.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 71.120000000000005 110.915 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 65.540000000000006 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.784 0.326 . . . . 72.43 110.789 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.17 -168.41 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.941 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.5 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 64.03 111.125 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.73 23.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 60.3 111.121 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 37.94 1.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 75.11 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -46.13 73.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.889 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.12 110.914 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.791 0.329 . . . . 65.01 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.88 -168.45 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.871 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.23 31.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.3 111.127 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 m -94.72 23.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 62.43 111.113 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 38.03 1.93 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.78 -0.724 . . . . 61.22 112.448 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -137.71 -53.31 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 70.11 110.872 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -52.04 35.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 71.2 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.781 0.324 . . . . 74.25 110.956 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -168.43 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 73.14 110.928 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.1 32.34 10.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.1 111.047 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.9 m -95.07 24.01 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 72.42 111.125 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.37 37.85 1.94 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.8 -0.714 . . . . 64.1 112.456 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.64 -52.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 71.43 110.837 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -27.06 65.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.876 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.905 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 74.44 110.845 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -168.55 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.34 110.943 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.33 31.62 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 70.43 111.062 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 m -94.91 23.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.025 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.14 37.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.24 112.479 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.77 -54.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 70.54 110.88 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -40.57 93.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 55.21 110.895 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.802 0.334 . . . . 71.31 110.863 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -168.38 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.907 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.2 32.01 10.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.3 111.082 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.1 23.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 74.12 111.033 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.02 37.8 1.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.811 -0.709 . . . . 74.22 112.535 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -137.64 -55.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.32 110.841 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 63.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 62.54 110.877 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.728 0.299 . . . . 74.54 110.8 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -168.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.252 -0.431 . . . . 72.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.59 10.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.04 111.065 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -94.89 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.134 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.87 1.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 74.13 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.68 -55.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.13 110.83 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.74 94.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.907 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 63.11 110.899 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.75 0.309 . . . . 73.2 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 -168.41 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 72.4 110.899 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 32.1 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 72.31 111.108 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.12 23.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.075 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 37.86 1.94 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.819 -0.705 . . . . 73.44 112.539 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.71 -55.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 74.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.28 93.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.899 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 65.24 110.845 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 75.11 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -168.37 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 72.55 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.83 10.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 75.34 111.059 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.0 m -94.9 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 64.01 111.085 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.81 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.819 -0.705 . . . . 64.31 112.505 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 75.14 110.818 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -47.03 81.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.841 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.856 0.36 . . . . 73.14 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.35 -168.48 1.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.95 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.16 10.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.23 111.183 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.97 24.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 74.1 111.09 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.8 37.73 1.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.818 -0.706 . . . . 74.32 112.54 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.7 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 74.34 110.89 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -28.87 68.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 73.15 110.936 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 43.03 110.841 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.783 0.325 . . . . 74.13 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -168.44 2.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 70.44 110.939 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.89 10.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.092 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.94 23.88 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 43.25 111.065 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.15 37.89 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 63.24 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 73.13 110.865 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -44.91 91.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.924 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.857 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 64.04 110.889 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -168.51 2.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 62.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.25 23.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 73.41 111.036 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.3 37.83 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.03 112.517 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.78 -55.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 72.32 110.856 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -49.58 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.885 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.894 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.762 0.315 . . . . 72.4 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -168.38 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 63.21 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 32.26 10.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.103 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.8 m -95.18 24.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.33 111.063 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.47 37.81 1.94 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.505 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -137.71 -54.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 75.4 110.913 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -35.24 80.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 70.22 110.852 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.75 0.309 . . . . 71.4 110.814 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.58 -168.52 1.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 72.02 110.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.3 31.96 10.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.989 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.03 23.72 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 62.22 111.029 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.03 37.91 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.831 -0.699 . . . . 61.44 112.518 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.76 -55.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 72.42 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -42.77 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 63.13 110.836 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 52.3 110.811 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.768 0.318 . . . . 64.31 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -168.49 2.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 33.04 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.52 111.09 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.8 23.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.13 111.166 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 37.92 1.95 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.819 -0.705 . . . . 74.45 112.553 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.73 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 75.11 110.841 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -26.91 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.982 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.842 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.785 0.326 . . . . 74.21 110.822 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.54 -168.58 0.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.03 110.929 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.54 10.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.039 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.85 23.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.41 111.062 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 38.03 1.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 72.2 112.483 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.71 -53.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 73.24 110.857 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -41.75 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.922 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 64.55 110.86 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m170 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.782 0.325 . . . . 62.22 110.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -168.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 74.2 110.987 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.5 10.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 60.32 111.04 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.0 m -94.89 23.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 71.41 111.027 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.79 37.88 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 33.21 112.516 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -54.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 44.01 110.818 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -38.49 88.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 73.15 110.881 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 60.33 110.819 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 m170 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.758 0.313 . . . . 75.12 110.828 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -168.4 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.65 10.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.193 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -94.82 23.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 73.14 111.044 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.72 37.74 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 43.23 112.455 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.62 -52.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.01 110.829 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -50.79 36.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.12 110.928 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 74.02 110.928 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.804 0.335 . . . . 62.34 110.811 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -168.39 2.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.928 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 72.33 111.129 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -94.89 23.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 64.22 111.073 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.74 37.81 1.97 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.812 -0.709 . . . . 60.03 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.65 -55.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 71.23 110.857 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -47.07 82.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.12 110.905 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.912 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.692 0.282 . . . . 65.03 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -168.5 1.94 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.921 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.25 33.92 8.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 50.21 111.051 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.66 23.45 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.026 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.08 37.97 1.93 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.817 -0.706 . . . . 71.01 112.45 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.69 -52.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 65.34 110.875 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -44.83 68.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.52 110.922 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.33 110.883 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.743 0.306 . . . . 51.44 110.864 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.31 -168.46 2.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 53.43 110.906 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.16 32.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.41 111.069 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -94.89 23.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 40.34 111.034 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.26 37.78 1.95 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 24.44 112.473 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.74 -55.76 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.733 0.302 . . . . 75.31 110.816 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -41.63 98.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 71.12 110.915 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 65.54 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.536 -0.226 . . . . 74.11 112.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -114.35 145.6 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 72.02 110.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -53.87 -65.23 0.6 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.789 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.17 -168.41 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.941 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.5 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 64.03 111.125 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.73 23.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 60.3 111.121 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 37.94 1.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 75.11 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -46.13 73.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.889 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.12 110.914 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.536 -0.226 . . . . 64.11 112.536 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -95.11 139.58 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.351 . . . . 74.43 110.952 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -72.7 -66.91 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 65.01 110.869 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.88 -168.45 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.871 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.23 31.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.3 111.127 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 m -94.72 23.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 62.43 111.113 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 38.03 1.93 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.78 -0.724 . . . . 61.22 112.448 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -137.71 -53.31 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 70.11 110.872 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -52.04 35.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 71.2 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.553 -0.219 . . . . 50.55 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.04 125.22 29.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 61.53 110.872 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -57.28 -64.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 74.25 110.956 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -168.43 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 73.14 110.928 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.1 32.34 10.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.1 111.047 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.9 m -95.07 24.01 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 72.42 111.125 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.37 37.85 1.94 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.8 -0.714 . . . . 64.1 112.456 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.64 -52.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 71.43 110.837 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -27.06 65.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.876 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.905 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.492 -0.243 . . . . 71.22 112.492 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -154.49 179.62 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 71.14 110.879 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.77 -58.16 8.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.845 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -168.55 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.34 110.943 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.33 31.62 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 70.43 111.062 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 m -94.91 23.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.025 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.14 37.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.24 112.479 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.77 -54.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 70.54 110.88 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -40.57 93.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 55.21 110.895 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.433 -0.267 . . . . 55.04 112.433 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 149.58 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 71.12 110.839 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -101.04 -41.81 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 71.31 110.863 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -168.38 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.907 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.2 32.01 10.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.3 111.082 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.1 23.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 74.12 111.033 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.02 37.8 1.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.811 -0.709 . . . . 74.22 112.535 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -137.64 -55.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.32 110.841 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 63.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 62.54 110.877 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.513 -0.235 . . . . 71.14 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -102.92 152.02 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 75.15 110.918 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -118.41 -60.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.8 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -168.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.252 -0.431 . . . . 72.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.59 10.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.04 111.065 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -94.89 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.134 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.87 1.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 74.13 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.68 -55.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.13 110.83 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.74 94.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.907 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 63.11 110.899 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.499 -0.24 . . . . 71.54 112.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -116.61 90.65 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 75.44 110.894 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -53.93 -57.39 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.2 110.901 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 -168.41 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 72.4 110.899 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 32.1 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 72.31 111.108 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.12 23.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.075 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 37.86 1.94 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.819 -0.705 . . . . 73.44 112.539 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.71 -55.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 74.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.28 93.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.899 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 65.24 110.845 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.507 -0.237 . . . . 31.05 112.507 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -110.76 142.54 42.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 60.43 110.932 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.69 -64.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 75.11 110.846 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -168.37 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 72.55 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.83 10.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 75.34 111.059 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.0 m -94.9 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 64.01 111.085 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.81 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.819 -0.705 . . . . 64.31 112.505 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 75.14 110.818 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -47.03 81.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.841 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.448 -0.261 . . . . 65.24 112.448 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -85.62 176.01 8.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 72.04 110.901 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -54.06 -48.66 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 73.14 110.883 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.35 -168.48 1.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.95 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.16 10.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.23 111.183 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.97 24.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 74.1 111.09 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.8 37.73 1.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.818 -0.706 . . . . 74.32 112.54 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.7 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 74.34 110.89 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -28.87 68.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 73.15 110.936 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 43.03 110.841 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.464 -0.254 . . . . 73.44 112.464 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -129.12 176.29 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 72.51 110.888 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.05 -68.56 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.13 110.873 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -168.44 2.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 70.44 110.939 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.89 10.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.092 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.94 23.88 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 43.25 111.065 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.15 37.89 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 63.24 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 73.13 110.865 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -44.91 91.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.924 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.857 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.484 -0.246 . . . . 63.12 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -112.31 -179.06 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 74.42 110.867 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -114.51 -68.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 64.04 110.889 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -168.51 2.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 62.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.25 23.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 73.41 111.036 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.3 37.83 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.03 112.517 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.78 -55.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 72.32 110.856 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -49.58 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.885 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.894 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.475 -0.25 . . . . 54.43 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.15 83.86 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 74.01 110.851 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -53.76 -59.74 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 72.4 110.831 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -168.38 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 63.21 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 32.26 10.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.103 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.8 m -95.18 24.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.33 111.063 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.47 37.81 1.94 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.505 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -137.71 -54.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 75.4 110.913 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -35.24 80.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 70.22 110.852 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.462 -0.255 . . . . 74.33 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.37 149.66 48.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.379 . . . . 72.25 110.868 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -99.18 -62.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.814 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.58 -168.52 1.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 72.02 110.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.3 31.96 10.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.989 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.03 23.72 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 62.22 111.029 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.03 37.91 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.831 -0.699 . . . . 61.44 112.518 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.76 -55.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 72.42 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -42.77 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 63.13 110.836 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 52.3 110.811 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.522 -0.231 . . . . 65.41 112.522 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -139.08 161.61 36.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.367 . . . . 74.12 110.875 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -77.4 -71.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 64.31 110.905 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -168.49 2.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 33.04 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.52 111.09 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.8 23.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.13 111.166 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 37.92 1.95 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.819 -0.705 . . . . 74.45 112.553 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.73 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 75.11 110.841 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -26.91 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.982 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.842 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.396 -0.282 . . . . 75.14 112.396 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -173.83 131.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 70.15 110.842 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -105.36 -25.92 12.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.822 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.54 -168.58 0.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.03 110.929 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.54 10.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.039 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.85 23.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.41 111.062 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 38.03 1.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 72.2 112.483 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.71 -53.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 73.24 110.857 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -41.75 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.922 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 64.55 110.86 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.465 -0.254 . . . . 62.32 112.465 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -116.13 123.0 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 75.41 110.873 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -97.79 -26.18 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 62.22 110.888 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -168.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 74.2 110.987 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.5 10.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 60.32 111.04 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.0 m -94.89 23.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 71.41 111.027 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.79 37.88 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 33.21 112.516 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -54.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 44.01 110.818 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -38.49 88.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 73.15 110.881 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 60.33 110.819 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.473 -0.251 . . . . 63.15 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.32 114.16 26.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 73.21 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -79.16 -52.32 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.12 110.828 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -168.4 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.65 10.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.193 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -94.82 23.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 73.14 111.044 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.72 37.74 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 43.23 112.455 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.62 -52.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.01 110.829 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -50.79 36.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.12 110.928 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 74.02 110.928 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.478 -0.249 . . . . 33.04 112.478 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -121.99 168.07 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 75.21 110.894 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.05 -71.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 62.34 110.811 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -168.39 2.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.928 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 72.33 111.129 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -94.89 23.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 64.22 111.073 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.74 37.81 1.97 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.812 -0.709 . . . . 60.03 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.65 -55.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 71.23 110.857 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -47.07 82.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.12 110.905 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.912 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.494 -0.242 . . . . 51.5 112.494 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.46 161.34 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.34 . . . . 71.43 110.963 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -125.7 -57.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 65.03 110.796 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -168.5 1.94 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.921 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.25 33.92 8.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 50.21 111.051 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.66 23.45 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.026 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.08 37.97 1.93 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.817 -0.706 . . . . 71.01 112.45 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.69 -52.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 65.34 110.875 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -44.83 68.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.52 110.922 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.33 110.883 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.449 -0.261 . . . . 61.52 112.449 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.61 137.84 37.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 64.1 110.853 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -75.96 -66.08 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 51.44 110.864 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.31 -168.46 2.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 53.43 110.906 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.16 32.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.41 111.069 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -94.89 23.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 40.34 111.034 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.26 37.78 1.95 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 24.44 112.473 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.74 -55.76 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.733 0.302 . . . . 75.31 110.816 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -41.63 98.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 71.12 110.915 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 65.54 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.784 0.326 . . . . 72.43 110.789 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.17 -168.41 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.941 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.5 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 64.03 111.125 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.73 23.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 60.3 111.121 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 37.94 1.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 75.11 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -46.13 73.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.889 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.12 110.914 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.791 0.329 . . . . 65.01 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.88 -168.45 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.871 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.23 31.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.3 111.127 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 m -94.72 23.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 62.43 111.113 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 38.03 1.93 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.78 -0.724 . . . . 61.22 112.448 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -137.71 -53.31 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 70.11 110.872 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -52.04 35.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 71.2 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.781 0.324 . . . . 74.25 110.956 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -168.43 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 73.14 110.928 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.1 32.34 10.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.1 111.047 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.9 m -95.07 24.01 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 72.42 111.125 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.37 37.85 1.94 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.8 -0.714 . . . . 64.1 112.456 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.64 -52.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 71.43 110.837 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -27.06 65.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.876 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.905 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.805 0.336 . . . . 74.44 110.845 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -168.55 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.34 110.943 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.33 31.62 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 70.43 111.062 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 m -94.91 23.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.025 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.14 37.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.24 112.479 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.77 -54.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 70.54 110.88 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -40.57 93.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 55.21 110.895 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.802 0.334 . . . . 71.31 110.863 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -168.38 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.907 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.2 32.01 10.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.3 111.082 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.1 23.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 74.12 111.033 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.02 37.8 1.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.811 -0.709 . . . . 74.22 112.535 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -137.64 -55.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.32 110.841 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 63.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 62.54 110.877 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.728 0.299 . . . . 74.54 110.8 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -168.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.252 -0.431 . . . . 72.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.59 10.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.04 111.065 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -94.89 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.134 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.87 1.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 74.13 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.68 -55.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.13 110.83 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.74 94.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.907 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 63.11 110.899 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.75 0.309 . . . . 73.2 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 -168.41 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 72.4 110.899 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 32.1 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 72.31 111.108 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.12 23.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.075 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 37.86 1.94 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.819 -0.705 . . . . 73.44 112.539 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.71 -55.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 74.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.28 93.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.899 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 65.24 110.845 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 75.11 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -168.37 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 72.55 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.83 10.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 75.34 111.059 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.0 m -94.9 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 64.01 111.085 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.81 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.819 -0.705 . . . . 64.31 112.505 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 75.14 110.818 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -47.03 81.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.841 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.856 0.36 . . . . 73.14 110.883 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.35 -168.48 1.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.95 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.16 10.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.23 111.183 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.97 24.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 74.1 111.09 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.8 37.73 1.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.818 -0.706 . . . . 74.32 112.54 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.7 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 74.34 110.89 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -28.87 68.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 73.15 110.936 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 43.03 110.841 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.783 0.325 . . . . 74.13 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -168.44 2.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 70.44 110.939 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.89 10.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.092 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.94 23.88 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 43.25 111.065 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.15 37.89 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 63.24 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 73.13 110.865 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -44.91 91.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.924 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.857 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 64.04 110.889 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -168.51 2.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 62.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.25 23.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 73.41 111.036 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.3 37.83 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.03 112.517 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.78 -55.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 72.32 110.856 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -49.58 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.885 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.894 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.762 0.315 . . . . 72.4 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -168.38 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 63.21 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 32.26 10.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.103 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.8 m -95.18 24.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.33 111.063 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.47 37.81 1.94 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.505 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -137.71 -54.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 75.4 110.913 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -35.24 80.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 70.22 110.852 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.75 0.309 . . . . 71.4 110.814 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.58 -168.52 1.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 72.02 110.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.3 31.96 10.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.989 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.03 23.72 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 62.22 111.029 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.03 37.91 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.831 -0.699 . . . . 61.44 112.518 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.76 -55.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 72.42 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -42.77 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 63.13 110.836 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 52.3 110.811 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.768 0.318 . . . . 64.31 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -168.49 2.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 33.04 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.52 111.09 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.8 23.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.13 111.166 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 37.92 1.95 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.819 -0.705 . . . . 74.45 112.553 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.73 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 75.11 110.841 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -26.91 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.982 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.842 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.785 0.326 . . . . 74.21 110.822 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.54 -168.58 0.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.03 110.929 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.54 10.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.039 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.85 23.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.41 111.062 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 38.03 1.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 72.2 112.483 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.71 -53.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 73.24 110.857 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -41.75 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.922 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 64.55 110.86 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m170 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.782 0.325 . . . . 62.22 110.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -168.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 74.2 110.987 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.5 10.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 60.32 111.04 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.0 m -94.89 23.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 71.41 111.027 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.79 37.88 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 33.21 112.516 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -54.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 44.01 110.818 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -38.49 88.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 73.15 110.881 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 60.33 110.819 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 m170 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.758 0.313 . . . . 75.12 110.828 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -168.4 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.65 10.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.193 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -94.82 23.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 73.14 111.044 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.72 37.74 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 43.23 112.455 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.62 -52.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.01 110.829 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -50.79 36.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.12 110.928 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 74.02 110.928 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.804 0.335 . . . . 62.34 110.811 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -168.39 2.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.928 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 72.33 111.129 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -94.89 23.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 64.22 111.073 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.74 37.81 1.97 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.812 -0.709 . . . . 60.03 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.65 -55.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 71.23 110.857 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -47.07 82.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.12 110.905 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.912 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.0 t60 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.692 0.282 . . . . 65.03 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -168.5 1.94 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.921 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.25 33.92 8.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 50.21 111.051 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.66 23.45 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.026 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.08 37.97 1.93 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.817 -0.706 . . . . 71.01 112.45 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.69 -52.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 65.34 110.875 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -44.83 68.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.52 110.922 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.33 110.883 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.743 0.306 . . . . 51.44 110.864 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.31 -168.46 2.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 53.43 110.906 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.16 32.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.41 111.069 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -94.89 23.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 40.34 111.034 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.26 37.78 1.95 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 24.44 112.473 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.74 -55.76 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.733 0.302 . . . . 75.31 110.816 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -41.63 98.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 71.12 110.915 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 65.54 110.89 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.536 -0.226 . . . . 74.11 112.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -114.35 145.6 41.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.89 0.376 . . . . 72.02 110.825 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 t-160 -53.87 -65.23 0.6 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.789 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.17 -168.41 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 62.41 110.941 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.5 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 64.03 111.125 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -94.73 23.55 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 60.3 111.121 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 37.94 1.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 64.22 112.504 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 75.11 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -46.13 73.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 73.24 110.889 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.12 110.914 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.536 -0.226 . . . . 64.11 112.536 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -95.11 139.58 31.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.351 . . . . 74.43 110.952 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -72.7 -66.91 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.428 . . . . 65.01 110.869 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -77.88 -168.45 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.871 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.23 31.55 10.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 75.3 111.127 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.8 m -94.72 23.47 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 62.43 111.113 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.75 38.03 1.93 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.78 -0.724 . . . . 61.22 112.448 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -137.71 -53.31 0.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.791 0.329 . . . . 70.11 110.872 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.66 -52.04 35.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 71.2 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.827 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.553 -0.219 . . . . 50.55 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.04 125.22 29.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 61.53 110.872 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -57.28 -64.97 0.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 74.25 110.956 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -168.43 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 73.14 110.928 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.1 32.34 10.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.1 111.047 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.9 m -95.07 24.01 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 72.42 111.125 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.37 37.85 1.94 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.8 -0.714 . . . . 64.1 112.456 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.64 -52.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 71.43 110.837 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -27.06 65.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.876 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 73.11 110.905 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.492 -0.243 . . . . 71.22 112.492 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -154.49 179.62 8.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 71.14 110.879 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -54.77 -58.16 8.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.845 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -168.55 2.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.34 110.943 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.33 31.62 10.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 70.43 111.062 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.2 m -94.91 23.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 62.12 111.025 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.14 37.9 1.94 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.723 . . . . 73.24 112.479 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.77 -54.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 70.54 110.88 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -40.57 93.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.424 . . . . 55.21 110.895 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 63.24 110.823 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.433 -0.267 . . . . 55.04 112.433 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -120.91 149.58 42.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 71.12 110.839 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -101.04 -41.81 6.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 71.31 110.863 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.73 -168.38 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.907 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.2 32.01 10.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 73.3 111.082 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.1 23.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 74.12 111.033 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.02 37.8 1.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.811 -0.709 . . . . 74.22 112.535 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -137.64 -55.0 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 72.32 110.841 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.49 -42.17 92.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 63.0 110.877 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 62.54 110.877 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.513 -0.235 . . . . 71.14 112.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -102.92 152.02 21.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 75.15 110.918 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -118.41 -60.89 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.54 110.8 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -168.47 1.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.252 -0.431 . . . . 72.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.59 10.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 74.04 111.065 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.0 m -94.89 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.134 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.87 1.96 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 74.13 112.491 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.68 -55.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.826 0.346 . . . . 73.13 110.83 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.87 -39.74 94.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.907 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 63.11 110.899 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.499 -0.24 . . . . 71.54 112.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -116.61 90.65 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 75.44 110.894 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -53.93 -57.39 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.2 110.901 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.09 -168.41 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 72.4 110.899 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 32.1 10.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 72.31 111.108 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.9 m -95.12 23.92 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 73.32 111.075 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.16 37.86 1.94 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.819 -0.705 . . . . 73.44 112.539 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.71 -55.27 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 74.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.28 93.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 72.23 110.899 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 65.24 110.845 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.507 -0.237 . . . . 31.05 112.507 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -110.76 142.54 42.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.884 0.373 . . . . 60.43 110.932 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -55.69 -64.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 75.11 110.846 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.76 -168.37 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 72.55 110.904 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.83 10.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 75.34 111.059 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.0 m -94.9 23.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 64.01 111.085 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.71 37.81 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.819 -0.705 . . . . 64.31 112.505 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 75.14 110.818 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -47.03 81.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 72.35 110.841 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 N-CA-C 112.448 -0.261 . . . . 65.24 112.448 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -85.62 176.01 8.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 72.04 110.901 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -54.06 -48.66 70.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 73.14 110.883 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.35 -168.48 1.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 74.55 110.95 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.16 10.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.23 111.183 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.7 m -94.97 24.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 74.1 111.09 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.8 37.73 1.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.818 -0.706 . . . . 74.32 112.54 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -137.7 -53.96 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 74.34 110.89 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -28.87 68.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 73.15 110.936 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 43.03 110.841 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.464 -0.254 . . . . 73.44 112.464 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.12 176.29 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 72.51 110.888 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.05 -68.56 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 74.13 110.873 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -168.44 2.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 70.44 110.939 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.14 31.89 10.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.092 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.94 23.88 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 43.25 111.065 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.15 37.89 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 63.24 112.491 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.73 -55.75 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 73.13 110.865 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -44.91 91.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.924 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.22 110.857 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.484 -0.246 . . . . 63.12 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -112.31 -179.06 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 74.42 110.867 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -114.51 -68.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 64.04 110.889 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -168.51 2.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 62.23 111.092 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.25 23.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 73.41 111.036 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.3 37.83 1.94 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.769 -0.729 . . . . 73.03 112.517 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.78 -55.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 72.32 110.856 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.43 -49.58 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.885 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.894 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.475 -0.25 . . . . 54.43 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -125.15 83.86 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 74.01 110.851 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -53.76 -59.74 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 72.4 110.831 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.98 -168.38 1.78 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 63.21 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 32.26 10.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.103 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.8 m -95.18 24.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 75.33 111.063 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.47 37.81 1.94 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.505 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -137.71 -54.78 0.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.82 0.343 . . . . 75.4 110.913 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -35.24 80.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 71.11 110.924 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 70.22 110.852 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.462 -0.255 . . . . 74.33 112.462 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.37 149.66 48.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.897 0.379 . . . . 72.25 110.868 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -99.18 -62.54 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 71.4 110.814 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.58 -168.52 1.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 72.02 110.89 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.3 31.96 10.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.52 110.989 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.03 23.72 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 62.22 111.029 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.03 37.91 1.94 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.831 -0.699 . . . . 61.44 112.518 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.76 -55.46 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 72.42 110.892 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 -42.77 96.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 63.13 110.836 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 52.3 110.811 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.522 -0.231 . . . . 65.41 112.522 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -139.08 161.61 36.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.367 . . . . 74.12 110.875 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -77.4 -71.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 64.31 110.905 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -168.49 2.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.921 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 33.04 9.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 73.52 111.09 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -94.8 23.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 72.13 111.166 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 37.92 1.95 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.819 -0.705 . . . . 74.45 112.553 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.73 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.817 0.342 . . . . 75.11 110.841 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -26.91 44.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 72.21 110.982 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 71.25 110.842 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.396 -0.282 . . . . 75.14 112.396 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -173.83 131.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.837 0.351 . . . . 70.15 110.842 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -105.36 -25.92 12.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.142 -0.481 . . . . 74.21 110.822 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.54 -168.58 0.57 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.03 110.929 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.54 10.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.039 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.85 23.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 74.41 111.062 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.85 38.03 1.93 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 72.2 112.483 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -137.71 -53.83 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.873 0.368 . . . . 73.24 110.857 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.66 -41.75 83.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.53 110.922 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 64.55 110.86 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.465 -0.254 . . . . 62.32 112.465 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -116.13 123.0 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 75.41 110.873 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -97.79 -26.18 14.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 62.22 110.888 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -168.55 0.51 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 74.2 110.987 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.08 31.5 10.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 60.32 111.04 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 32.0 m -94.89 23.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 71.41 111.027 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.79 37.88 1.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.793 -0.718 . . . . 33.21 112.516 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -137.68 -54.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.895 0.379 . . . . 44.01 110.818 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -38.49 88.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 73.15 110.881 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 60.33 110.819 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.473 -0.251 . . . . 63.15 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.32 114.16 26.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 73.21 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -79.16 -52.32 8.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.12 110.828 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -73.07 -168.4 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.886 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.17 31.65 10.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 74.3 111.193 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.6 m -94.82 23.66 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 73.14 111.044 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.72 37.74 1.98 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 43.23 112.455 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -137.62 -52.33 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.01 110.829 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -50.79 36.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.12 110.928 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 74.02 110.928 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.478 -0.249 . . . . 33.04 112.478 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -121.99 168.07 12.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 75.21 110.894 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.05 -71.55 0.13 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 62.34 110.811 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.62 -168.39 2.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.928 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.15 32.25 10.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 72.33 111.129 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -94.89 23.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 64.22 111.073 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -132.74 37.81 1.97 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.812 -0.709 . . . . 60.03 112.545 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.65 -55.92 0.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 71.23 110.857 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -47.07 82.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 71.12 110.905 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.912 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.494 -0.242 . . . . 51.5 112.494 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -100.46 161.34 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.813 0.34 . . . . 71.43 110.963 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -125.7 -57.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 65.03 110.796 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -81.83 -168.5 1.94 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 73.42 110.921 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.25 33.92 8.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 50.21 111.051 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.66 23.45 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.026 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.08 37.97 1.93 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.817 -0.706 . . . . 71.01 112.45 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -137.69 -52.41 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.858 0.361 . . . . 65.34 110.875 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -44.83 68.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.52 110.922 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.7 mtm . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 64.33 110.883 179.799 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.449 -0.261 . . . . 61.52 112.449 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -99.61 137.84 37.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 64.1 110.853 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -75.96 -66.08 0.83 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 51.44 110.864 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -83.31 -168.46 2.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 53.43 110.906 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.16 32.23 10.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.41 111.069 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.6 m -94.89 23.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 40.34 111.034 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.26 37.78 1.95 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 24.44 112.473 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -137.74 -55.76 0.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.733 0.302 . . . . 75.31 110.816 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.73 -41.63 98.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 71.12 110.915 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 65.54 110.89 179.832 . . . . . . . . 1 1 . 1 stop_ save_